Consistent with their reported activation in various cancer types, including colon cancer (Astanina et al, 2021), we detected basal amounts of TFEB and TFE3 in nuclear fractions of control RKO cells by Western blotting analysis (Fig 4A). The gene discussed is TFEB; the disease is malignant colon neoplasm.